A trial looking at heated mitomycin C chemotherapy for bladder cancer (HIVEC II)

This trial looked at having heated mitomycin C into the bladder for non muscle invasive bladder cancer. Non muscle invasive bladder cancer means the cancer is only in the lining of the bladder. It has not grown into the deeper layers of the bladder wall.

This trial was for people with newly diagnosed bladder cancer or bladder cancer that had come back after initial treatment.

The trial was open for people to join between 2014 and 2017. The team published the results in 2023.